Can a simple checklist help childhood cancer survivors avoid hearing and vision loss?

NCT ID NCT05582551

First seen Jun 25, 2026 · Last updated Jun 25, 2026 · Updated 1 time

Summary

This study is testing a new tool called HPARSS that helps doctors identify childhood cancer survivors at risk for hearing or vision problems. The tool uses a patient's past cancer treatments to flag who needs screening. Researchers will see if this approach leads to more kids getting tested and treated for sensory issues. The study involves 146 survivors aged 7 to 17 who finished cancer therapy at least 6 months ago.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Louis Children's Hospital - Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple tool that helps doctors spot childhood cancer survivors who need hearing or vision tests, ensuring they get the right care sooner.

What could go wrong

This is a small, early-stage study focused on testing a process, not a treatment. The tool may not work in other hospitals or for all survivors, and it won't directly improve health without proper follow-up.

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm hearing loss disorder neoplasm peripheral nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.